241 — Alibaba Health Information Technology Income Statement
0.000.00%
- HK$95.46bn
- HK$86.66bn
- CNY30.60bn
- 91
- 14
- 99
- 81
Annual income statement for Alibaba Health Information Technology, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15,518 | 20,578 | 26,763 | 27,027 | 30,598 |
| Cost of Revenue | |||||
| Gross Profit | 3,617 | 4,108 | 5,701 | 5,895 | 7,432 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15,076 | 20,781 | 26,218 | 26,075 | 28,971 |
| Operating Profit | 442 | -203 | 545 | 951 | 1,627 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 401 | -253 | 551 | 939 | 1,560 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 343 | -266 | 537 | 883 | 1,432 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 349 | -266 | 536 | 883 | 1,432 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 349 | -266 | 536 | 883 | 1,432 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.021 | -0.038 | 0.035 | 0.058 | 0.115 |